Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology

Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology

PurposeSodium-glucose cotransporter 2 (SGLT2) inhibitors have cardiorenal protective effects regardless of whether they are combined with type 2 diabetes mellitus, but their specific pharmacological mechanisms remain undetermined.Materials and MethodsWe used databases to obtain information on the di...

Full description

Bibliographic Details
Main Authors: Anzhu Wang, Zhendong Li, Sun Zhuo, Feng Gao, Hongwei Zhang, Zhibo Zhang, Gaocan Ren, Xiaochang Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
type 2 diabetes mellitus
chronic kidney disease
heart failure
sodium-glucose cotransporter 2 inhibitors
cardiorenal protection
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.857952/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.857952/full

Similar Items